High Prevalence of AmpC β-Lactamases in Clinical Isolates of Escherichia coli in Ilam, Iran
10.1016/j.phrp.2015.02.001
- Author:
Abbas MALEKI
1
;
Afra KHOSRAVI
;
Sobhan GHAFOURIAN
;
Iraj PAKZAD
;
Shiva HOSSEINI
;
Rashid RAMAZANZADEH
;
Nourkhoda SADEGHIFARD
Author Information
1. Clinical Microbiology, Clinical Microbiology Research Center, Ilam University of Medical Science, Ilam, Iran
- Publication Type:Original Article
- From:
Osong Public Health and Research Perspectives
2015;6(3):201-204
- CountryRepublic of Korea
- Language:English
-
Abstract:
Objectives:Widespread use of β-lactam antibiotics could cause resistance to this group of antibiotics in pathogenic bacteria through the production of the enzyme β-lactamases. The aim of this study is to determine the molecular detection of AmpC β-lactamases among clinical Escherichia coli isolated from Ilam hospitals in Ilam, Iran.
Methods:One hundred and twelve clinical isolates of E. coli were collected from hospitalized patients and were identified by biochemical tests. They were evaluated for extended spectrum beta-lactamases (ESBLs) production, and the positive strains were subjected to AmpC enzymes; for detection of AmpC cluster genes, multiplex polymerase chain reaction was applied.
Results:The analysis showed 62.5% of isolates were ESBLs positive and that five strains revealed the AmpC cluster genes. This is the first report of FOXM cluster genes in E. coli in Iran.
Conclusion:Based on our results, the prevalence of AmpC β-lactamases is increasing in Iran, which caused failure in antibiotic therapy. So, the current study recommended the revision of antibiotic policy in Iranian hospitals.
